These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 25521304

  • 1. Levocetirizine and rupatadine in chronic idiopathic urticaria.
    Johnson M, Kwatra G, Badyal DK, Thomas EA.
    Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
    Staevska M, Gugutkova M, Lazarova C, Kralimarkova T, Dimitrov V, Zuberbier T, Church MK, Popov TA.
    Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
    [Abstract] [Full Text] [Related]

  • 6. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
    Sharma VK, Gupta V, Pathak M, Ramam M.
    J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
    [Abstract] [Full Text] [Related]

  • 7. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
    González-Núñez V, Bachert C, Mullol J.
    Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
    Sarkar TK, Sil A, Pal S, Ghosh C, Das NK.
    Indian J Dermatol Venereol Leprol; 2017 Oct; 83(5):561-568. PubMed ID: 28656910
    [Abstract] [Full Text] [Related]

  • 9. H1-antihistamines for chronic spontaneous urticaria.
    Sharma M, Bennett C, Cohen SN, Carter B.
    Cochrane Database Syst Rev; 2014 Nov 14; 2014(11):CD006137. PubMed ID: 25397904
    [Abstract] [Full Text] [Related]

  • 10. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria.
    Dubuske LM.
    Allergy Asthma Proc; 2007 Nov 14; 28(6):724-34. PubMed ID: 18201439
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chronic idiopathic urticaria with levamisole: a multicentre, randomized, double-blind, controlled trial.
    Zhang H, Shan C, Hua Z, Zhao P, Zhang H.
    J Int Med Res; 2009 Nov 14; 37(4):1167-72. PubMed ID: 19761700
    [Abstract] [Full Text] [Related]

  • 12. An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients.
    Fang SY, Perng DW, Lee JY, Lin DY, Huangs CY.
    Chin J Physiol; 2010 Aug 31; 53(4):199-207. PubMed ID: 21793329
    [Abstract] [Full Text] [Related]

  • 13. Rupatadine: a review of its use in the management of allergic disorders.
    Keam SJ, Plosker GL.
    Drugs; 2007 Aug 31; 67(3):457-74. PubMed ID: 17335300
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial.
    Hide M, Suzuki T, Tanaka A, Aoki H.
    J Dermatol Sci; 2019 Jun 31; 94(3):339-345. PubMed ID: 31196788
    [Abstract] [Full Text] [Related]

  • 15. Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study.
    Gayathri E, Sowmya P, Punnagai K, Mahalakshmi V.
    Indian J Dermatol Venereol Leprol; 2023 Jun 31; 89(5):672-679. PubMed ID: 37067147
    [Abstract] [Full Text] [Related]

  • 16. Rupatadine for the treatment of urticaria.
    Nettis E, Delle Donne P, Di Leo E, Calogiuri GF, Ferrannini A, Vacca A.
    Expert Opin Pharmacother; 2013 Sep 31; 14(13):1807-13. PubMed ID: 23806068
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Podder I, Das A, Ghosh S, Biswas D, Sengupta S, Chowdhury SN.
    Dermatol Ther; 2020 Nov 31; 33(6):e13946. PubMed ID: 32618048
    [Abstract] [Full Text] [Related]

  • 18. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
    Izquierdo I, Merlos M, García-Rafanell J.
    Drugs Today (Barc); 2003 Jun 31; 39(6):451-68. PubMed ID: 12944997
    [Abstract] [Full Text] [Related]

  • 19. Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria.
    Abajian M, Curto-Barredo L, Krause K, Santamaria E, Izquierdo I, Church MK, Maurer M, Giménez-Arnau A.
    Acta Derm Venereol; 2016 Jan 31; 96(1):56-9. PubMed ID: 26038847
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria.
    Handa S, Dogra S, Kumar B.
    J Dermatolog Treat; 2004 Jan 31; 15(1):55-7. PubMed ID: 14754652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.